Cognitive Impairment Associated with Schizophrenia
📧 Sign up to get email alerts when something new happens for Cognitive Impairment Associated with Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: TIS for Improving Cognitive Impairment Associated With Schizophrenia [NA]
Central South University is conducting a clinical trial to evaluate TIS for cognitive impairment associated with schizophrenia, and the stud…
-
CLINICAL_TRIALS research · 2025-09-25Clinical Trial Update: A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia [Phase 2]
A Phase 2 clinical trial evaluating KYN-5356 for cognitive impairment associated with schizophrenia is currently recruiting. Sponsor: Kynexi…
-
CLINICAL_TRIALS trial_result · 2025-07-30Clinical Trial Update: A Study to Evaluate RL-007 in the Treatment of Cognitive Impairment Associated With Schizophrenia (CIAS) [Phase 2]
Phase 2 trial evaluating RL-007 for cognitive impairment associated with schizophrenia (CIAS) has completed.
-
CLINICAL_TRIALS trial_result · 2024-11-29Clinical Trial Update: Evoked Responses as Pharmacodynamic Biomarkers in Healthy and Schizophrenic Participants (MK-4334-007) [Phase 1]
Phase 1 clinical trial update reporting results of evaluating evoked responses as pharmacodynamic biomarkers in healthy participants and ind…
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of BIIB104 in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS) [Phase 2]
Phase 2 trial evaluating BIIB104 for cognitive impairment associated with schizophrenia has completed enrollment and results were posted in …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-10-04Clinical Trial Update: A Study To Evaluate The Safety And Efficacy Of PF-04958242 In Subjects With Cognitive Impairment Associated With Schizophrenia (CIAS) [Phase 2]
Phase 2 trial of PF-04958242 for cognitive impairment in schizophrenia was terminated in 2017; results posted but no further development ind…
-
CLINICAL_TRIALS trial_result · 2008-12-08Clinical Trial Update: Study to Evaluate the Safety and Efficacy of MEM 3454 as Adjunctive Treatment in Combination With a Preexisting Antipsychotic in Patients With Cognitive Impairment Associated With Schizophrenia [Phase 2]
A Phase 2 clinical trial evaluating MEM 3454 as an adjunct to an existing antipsychotic for cognitive impairment associated with schizophren…